CEI
AKYA

Clark Estates Inc’s Akoya BioSciences AKYA Stock Holding History

Clark Estates Inc’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-170,541
Closed -$1.63M – 89
2022
Q4 		$1.63M Sell
170,541
-1,435
-0.8% -$17.7K 0.34% 80
2022
Q3 		$2.02M Sell
171,976
-1,130
-0.7% -$14.9K 0.45% 78
2022
Q2 		$2.22M Buy
+173,106
New +$1.79M 0.39% 83

Other funds holding AKYA

BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Clark Estates Inc's AKYA Position: Q1 2023 in Review

Clark Estates Inc sold out of Akoya BioSciences (AKYA) in Q1 2023, closing a stake of 170,541 shares — an estimated $1.63M sold.

Clark Estates Inc first reported a position in AKYA in Q2 2022 and held it in 3 quarters. The position peaked at $2.22M in Q2 2022. 63 funds tracked by Wall St. Rank hold AKYA as of Q1 2023.

  • Clark Estates Inc reported no remaining Akoya BioSciences position as of Q1 2023 after selling out during the quarter.
  • Clark Estates Inc sold 170,541 Akoya BioSciences shares in Q1 2023, an estimated $1.63M.
  • Clark Estates Inc first reported a position in Akoya BioSciences in Q2 2022 and held it in 3 quarters.
  • Clark Estates Inc's Akoya BioSciences position peaked at $2.22M in Q2 2022.
  • 63 funds tracked by Wall St. Rank held Akoya BioSciences as of Q1 2023.

Based on Clark Estates Inc's 13F filing for Q1 2023, filed 12 May 2023.